ArticleBMC gastroenterology2026
Associations of abnormal blood lipid levels with hospitalization cost and disease severity in patients with hyperlipidemic pancreatitis: a retrospective cohort study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperlipidemic pancreatitis (HLP) carries a considerable clinical and economic burden. This retrospective study examined how abnormal blood lipid levels relate to hospitalization cost and disease severity in patients with HLP, with the aim of informing risk stratification and lipid management in clinical practice.
methodsWe retrospectively reviewed 117 patients with HLP accounting for 171 hospitalizations at Jen Ching Memorial Hospital between January 2018 and June 2025. Total hospitalization cost (THC) was analyzed by gamma regression and length of stay (LOS) by negative binomial regression, with cluster-robust standard errors to account for repeated hospitalizations in the same patient.
resultsAt the first hospitalization, the median triglyceride (TG) level was 13.56 mmol/L and the median total cholesterol (TC) level was 8.89 mmol/L. The median LOS was 6 days and the median THC was 10,920.44 yuan (US$1,528.85). In multivariable analyses, both lipids were positively associated with THC. Each 1 mmol/L increase in TG corresponded to a 2.2% higher THC (approximately 240 yuan; US$33.60) (rate ratio [RR] = 1.022, 95% confidence interval [CI] = 1.008-1.040, P = 0.013). Each 1 mmol/L increase in TC corresponded to a 5.3% higher THC (approximately 580 yuan; US$81.20) (RR = 1.053, 95% CI = 1.004-1.098, P = 0.046). Higher TG levels were further associated with greater odds of intensive care unit (ICU) transfer and complications.
conclusionHigher TG and TC levels were associated with greater hospitalization cost, and higher TG levels with severity-related indicators. These associations suggest that lipid levels may be useful for risk stratification in patients with HLP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.